Drug of Abuse Testing Market By Product Type (Analyzers, Rapid Testing Devices and Consumables), Sample Type (Saliva, Urine, Blood and Other Sample Types), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories and Other End Users) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Drugs Of Abuse Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.6%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Drugs of Abuse Testing Market Dynamics Drivers

Urine drug testing is routinely utilised in clinical, employment, educational, and legal contexts, and incorrect results interpretation can have serious negative effects on the person being tested. Clinicians face difficulties when trying to correctly interpret urine drug test results because of improvements in drug testing technology as well as an increase in the number of novel chemicals that are abused. Because urine testing is rapid, noninvasive, and capable of detecting a wide range of substances, it is the most popular. Depending on the medication used, it may be able to detect medicines that were used within the last 1 to 4 days, or even longer. Recent scientific advancements in the equipment and materials used to test urine samples for drugs of abuse have made these tests, when properly executed, highly accurate for cannabis and cocaine, the two most common drugs of abuse.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Drugs Of Abuse Testing Market Segmentation

Product Type
  • Analyzers
  • Rapid Testing Devices
  • Consumables
Sample Type
  • Saliva
  • Urine
  • Blood
  • Other Sample Types
End-User
  • Hospitals
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Other End Users

Frequently Asked Questions

The drug of abuse testing market is projected to expand at a CAGR of 5.6% during the forecast period.

Siemens Healthineers, Thermo Fisher Scientific Inc., Drägerwerk AG & Co., Hoffmann-La Roche Ltd., Danaher Corporation

North America is the fastest-growing region for drug of abuse testing market

  • Danaher Corporation
  • LabCorp
  • Abbott Laboratories
  • Quest Diagnostics, Inc.
  • Cordant Health Solutions
  • DrugScan
  • Legacy Medical Services
  • Mayo Clinic Laboratories
  • LGC Group
  • Precision Diagnostics

Adjacent Markets